Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rémi Delva"'
Autor:
Florian Estrade, Magalie P. Tardy, Damien Pouessel, Morgan Rouprêt, Benoit Rousseau, Hélène Gauthier, Pernelle Lavaud, Marianne Lorcet, Yann Neuzillet, Thierry Lebret, Nadine Houede, Yohann Loriot, Yves Allory, Stéphane Culine, Brigitte Laguerre, Camelia Radulescu, Gwenaelle Gravis, Delphine Borchiellini, Stéphane Oudard, Marine Gross-Goupil, Marine Sroussi, Aude Flechon, Sophie Tartas, Rémi Delva, Olivier Huillard, Nicolas Penel, Elodie Mussat, Aurélien Gobert, Phillipe Barthélémy, Reza Elaidi, Mathilde Guerin
Publikováno v:
Clinical Genitourinary Cancer
Clinical Genitourinary Cancer, Elsevier, 2019, ⟨10.1016/j.clgc.2019.11.014⟩
Clinical Genitourinary Cancer, 2019, ⟨10.1016/j.clgc.2019.11.014⟩
Clinical Genitourinary Cancer, Elsevier, 2019, ⟨10.1016/j.clgc.2019.11.014⟩
Clinical Genitourinary Cancer, 2019, ⟨10.1016/j.clgc.2019.11.014⟩
International audience; BACKGROUND:Neuroendocrine carcinoma of the urinary bladder (NCUB) is rare, accounting for < 1% of bladder cancer cases, with scarce reported data available.MATERIALS AND METHODS:We retrospectively reviewed the data from patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6607d9ac43aa8830d47353843551a856
https://hal.umontpellier.fr/hal-02556645
https://hal.umontpellier.fr/hal-02556645
Autor:
A. Caty, Stéphane Culine, Rémi Delva, Agnès Laplanche, Frank Priou, Philippe Beuzeboc, Christine Chevreau, Frederic Rolland, Pierre Kerbrat, Lionnel Geoffrois, Jean-pierre Malhaire, Olivier Rixe, Karim Fizazi, Marie-Stephanie Aubelle
Publikováno v:
European Urology. 65:381-386
Background Whether patients with good prognosis and intermediate/poor prognosis advanced seminoma should be treated differently has not been defined. Objective To assess a risk-adapted chemotherapy regimen in patients with advanced seminoma. Design,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ffc15d121f7ec19eea479a98062dd1a
https://doi.org/10.1016/j.eururo.2013.09.004
https://doi.org/10.1016/j.eururo.2013.09.004
Autor:
Jean-Yves Pierga, Marie-Christine Etienne-Grimaldi, Patricia Formento, Mireille Francoual, Gérard Milano, Florence Dalenc, A. Degeorges, Rémi Delva, Xavier Pivot, Marc Espié, Corinne Veyret, Patricia de Cremoux, Jean-Louis Formento, Magali Piutti
Publikováno v:
British Journal of Clinical Pharmacology. 71:921-928
AIMS To test prospectively the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-chemotherapy in breast cancer patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6423fb6e41ae017b0159b4ab9bea0e43
https://doi.org/10.1111/j.1365-2125.2010.03896.x
https://doi.org/10.1111/j.1365-2125.2010.03896.x
Autor:
Jacques Dauplat, S. Amat, Frédérique Penault-Llorca, Bruno Coudert, Philippe Chollet, Bernard Leduc, Marie-Ange Mouret-Reynier, Rémi Delva, Marianne Leheurteur, Hervé Curé
Publikováno v:
Clinical Breast Cancer. 7:262-269
Background The objective of this phase II study was to attempt to maximize response and survival in patients with bulky, operable breast cancer by combining sequential neoadjuvant docetaxel to a semi-intensive anthracycline- based regimen. Patients a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad76816a71d17e28466bb74d6d519760
https://doi.org/10.3816/cbc.2006.n.039
https://doi.org/10.3816/cbc.2006.n.039
Autor:
Sophie, Amat, Sophie Catherine, Abrial, Catherine, Abrial, Frédérique, Penault-Llorca, Rémi, Delva, Philippe, Bougnoux, Bernard, Leduc, Marie-Ange, Mouret-Reynier, Dominique, Mery-Mignard, Jean-Pierre, Bleuse, Jacques, Dauplat, Hervé, Curé, Philippe, Chollet
Publikováno v:
Breast Cancer Research and Treatment. 94:255-263
Prognostic factors are used to help clinical decision-making in selecting the appropriate treatment for individual patients. The purpose of this retrospective study was to identify one or more factors associated with overall survival (OS) and disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1df46682be59ec9fe4158783ab1b011
https://doi.org/10.1007/s10549-005-9008-8
https://doi.org/10.1007/s10549-005-9008-8
Autor:
Marie-Christine, Etienne-Grimaldi, Patricia, Formento, Armelle, Degeorges, Jean-Yves, Pierga, Rémi, Delva, Xavier, Pivot, Florence, Dalenc, Marc, Espié, Corinne, Veyret, Jean-Louis, Formento, Mireille, Francoual, Magali, Piutti, Patricia, de Crémoux, Gérard, Milano
Publikováno v:
British journal of clinical pharmacology. 71(6)
• Functional polymorphisms on the VEGF-A gene, known to be linked to cancer risk or to VEGF-A plasma concentrations, have been identified. So far, limited knowledge has been published on the relationships between toxicity/efficacy of bevacizumab-ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3557a181abeacae60c8ab2879fb0d150
https://pubmed.ncbi.nlm.nih.gov/21204912
https://pubmed.ncbi.nlm.nih.gov/21204912
Autor:
Erick Gamelin, Bernard Leduc, Philippe Chollet, Rémi Delva, J. Fleury, Frédérique Penault-Llorca, Catherine Abrial, Isabelle Van Praagh, Isabelle Sillet-Bach, S. Amat
Publikováno v:
The oncologist. 10(4)
This phase II study investigated the efficacy and tolerability of a primary chemotherapy regimen combining vinorelbine, epirubicin, and paclitaxel (VEP protocol) in women with stage II/III operable breast cancer. Patients (n = 50) were treated with s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b28d9ec20cc5b706adb32bc19cd7fe7f
https://pubmed.ncbi.nlm.nih.gov/15821244
https://pubmed.ncbi.nlm.nih.gov/15821244
Autor:
Sophie Abrial, Frédérique Penault-Llorca, Rémi Delva, Philippe Bougnoux, Bernard Leduc, Marie-Ange Mouret-Reynier, Dominique Mery-Mignard, Jean-Pierre Bleuse, Jacques Dauplat, Hervé Curé, Philippe Chollet
Publikováno v:
Breast Cancer Research & Treatment; Aug2006, Vol. 98 Issue 3, p365-365, 1p